21 July 2020 : Case report
A Rare Case of Non-Prosthetic Aortic Valve Infectious Endocarditis Caused by Achromobacter xylosoxidans
Rare disease
Ricardo Lessa de Castro1ABCDEF*, Neiberg de Alcantara Lima1CDEF, Danielli Oliveira da Costa Lino2BCDF, Thomas Austin Melgar1ACDEFDOI: 10.12659/AJCR.923031
Am J Case Rep 2020; 21:e923031
Table 1. Reported cases of IE.
Author | Age | Risk of IE | Comorbidities | Valve | Prosthetic | Antibiotic | Surgery | Died | |
---|---|---|---|---|---|---|---|---|---|
This case | 19 y | CS, Bicuspid aortic valve | None | Ao | No | Meropenem | Yes | No | |
Levoy et al. []8 | 6 m | IVC+ calcified MV | Arterial calcification | M | No | Piperacillin-tazobactam+ TMP-SMX+colistin+ meropenem+levofloxacin | No | No | |
Tea et al. []9 | 67 y | Rheumatic mitral stenosis, asplenia | Asplenia | M | No | Piperacillin-sulbactam+ Imipenem | Yes | NA | |
Rodrigues et al. []10 | 86 y | None | IHD, lung fibrosis, CKD, plymyalgia | Ao | No | Piperacillin-tazobactam+ TMP-SMX | No | No | |
Derber et al. []11 | 54 y | PV+ Fallot’s T | Fallot’s T | P | Yes | Piperacillin-tazobactam+ Imipenem-Cilastatin Levofloxacin | Yes | No | |
Kumar et al. []13 | 54 y | NA | CKD, CRF, H | M+Ao | No | Vancomycin+piperacillin-tazobactam+gentamicin | Yes | NA | |
Rafael et al. []14 | 50 y | CS | VSDR | P+RVOT | No | NA | Yes | No | |
Sawant et al. []15 | 62 y | PV+PM | AF, CHF, COPD, CKD | M+Ao+PM | Yes/No/– | Piperacillin-tazobactam+ TMP-SMX+amikacin+ meropenem+rifampicin | Yes | No | |
Tokuyasu et al. []16 | 86 y | PV | NA | Ao | Yes | Carbapenem | No | Yes | |
Store et al. []17 | 79 y | None | H, AF, TIA | M+Ao | No | Meropenem | No | Yes | |
Malek-Marín et al. []18 | 50 y | Catheter | CKD | NA | – | NA | Yes | Yes | |
Ahmed et al. []19 | 69 y | PV | DM, H, CKD, CABG | M+Ao | No/Yes | Ertapenem+Tigecycline+ TMP-SMX | Yes | Yes | |
van Hal et al. []20 | 37 y | PV+IDU | NA | Ao | Yes | Carbapenem | Yes | No | |
Yang et al. []21 | 35 y | IDU+TR+MP | Hepatitis C | T | No | Piperacillin-tazobactam+ Amikacin+Ceftazidime | Yes | NA | |
Nanuashvili et al. []22 | 46 y | None | DM, Emphysema, IS | M+Ao | No | Ampicillin+Sulbactam+ Cotrimoxazole | Yes | No | |
Ahn et al. []23 | 35 y | CS+PM | VSDR, CHB with PM | PM+RVOT | – | Ceftazidime+Amikacin | Yes | No | |
Martino et al. []24 | 33 y | IVC | Bone marrow transplant | NA | – | Aztreonam+Amikacin | No | Yes | |
Davis et al. []25 | 30 y | NA | HF | NA | – | None | No | Yes | |
Lofgren et al. []26 | 77 y | PV | Rheumatic dis.+ PV | M+Ao | No/Yes | Tobramycin+Carbenicillin+ TMP-SMX+Moxalactam | No | Yes | |
Bhattarai et al. []27 | 37 y | IDU+PV | NA | M | Yes | Meropenem | Yes | No | |
Olson et al. []28 | 35 y | Aortic surgery+PV | NA | Ao | Yes | Carbenicillin+ TMP-SMX+ Rifampicin+ Moxalactam+Azlocillin | No | Yes | |
AF – atrial fibrillation; Ao – aortic; CABG – coronary artery bypass grafting; CHB – complete heart block; CHF – congestive heart failure; CKD – chronic kidney disease; COPD – chronic obstructive pulmonary disease; CS – cardiac surgery; DM – diabetes mellitus; H – hypertension; HF – heart failure; IDU – intravenous drug user; IHD – ischemic heart disease; IS – ischemic stroke; IVC – intravenous catheter; M – mitral; NA – not available; P – pulmonary; PM – pacemaker; PV – prosthetic valve; RVOT – right ventricular outflow tract; T – tricuspid; TIA – transient ischemic accident; TMP-SMX – trimethoprim-sulfamethoxazole; TR – tricuspid regurgitation; VSDR – ventricular septal defect repair. |